Randomized Trial: Neoadjuvant Chemoradiotherapy Followed by Surgery vs. Surgery Alone for Locally Advanced Esophageal Cancer

Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial – Journal of Clinical Oncology (free)

Commentary: Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Cancer – The ASCO Post (free)

Source: EvidenceAlerts